» Articles » PMID: 23603977

NVP-BEZ235, a Novel Dual PI3K/mTOR Inhibitor, Enhances the Radiosensitivity of Human Glioma Stem Cells in Vitro

Overview
Specialty Pharmacology
Date 2013 Apr 23
PMID 23603977
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: NVP-BEZ235 is a novel dual PI3K/mTOR inhibitor and shows dramatic effects on gliomas. The aim of this study was to investigate the effects of NVP-BEZ235 on the radiosensitivity and autophagy of glioma stem cells (GSCs) in vitro.

Methods: Human GSCs (SU-2) were tested. The cell viability and survival from ionizing radiation (IR) were evaluated using MTT and clonogenic survival assay, respectively. Immunofluorescence assays were used to identify the formation of autophagosomes. The apoptotic cells were quantified with annexin V-FITC/PI staining and flow cytometry, and observed using Hoechst 33258 staining and fluorescence microscope. Western blot analysis was used to analyze the expression levels of proteins. Cell cycle status was determined by measuring DNA content after staining with PI. DNA repair in the cells was assessed using a comet assay.

Results: Treatment of SU-2 cells with NVP-BEZ235 (10-320 nmol/L) alone suppressed the cell growth in a concentration-dependent manner. A low concentration of NVP-BEZ235 (10 nmol/L) significantly increased the radiation sensitivity of SU-2 cells, which could be blocked by co-treatment with 3-MA (50 μmol/L). In NVP-BEZ235-treated SU-2 cells, more punctate patterns of microtubule-associated protein LC3 immunoreactivity was observed, and the level of membrane-bound LC3-II was significantly increased. A combination of IR with NVP-BEZ235 significantly increased the apoptosis of SU-2 cells, as shown in the increased levels of BID, Bax, and active caspase-3, and decreased level of Bcl-2. Furthermore, the combination of IR with NVP-BEZ235 led to G1 cell cycle arrest. Moreover, NVP-BEZ235 significantly attenuated the repair of IR-induced DNA damage as reflected by the tail length of the comet.

Conclusion: NVP-BEZ235 increases the radiosensitivity of GSCs in vitro by activating autophagy that is associated with synergistic increase of apoptosis and cell-cycle arrest and decrease of DNA repair capacity.

Citing Articles

Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities.

Jiang Z, Allkanjari M, Chung P, Tran H, Ghanbari-Azarnier R, Wang D Cancers (Basel). 2025; 17(5).

PMID: 40075567 PMC: 11898778. DOI: 10.3390/cancers17050720.


Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research.

Son B, Lee W, Kim H, Shin H, Park H Cell Death Dis. 2024; 15(9):696.

PMID: 39349424 PMC: 11442590. DOI: 10.1038/s41419-024-07077-8.


MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome.

Taeb S, Rostamzadeh D, Amini S, Rahmati M, Eftekhari M, Safari A Cancer Cell Int. 2024; 24(1):233.

PMID: 38965615 PMC: 11229485. DOI: 10.1186/s12935-024-03420-3.


USP9X inhibits metastasis in pulmonary sarcomatoid carcinoma by regulating epithelial-mesenchymal transition, angiogenesis and immune infiltration.

Feng Q, Liu Q, Liu Z, Xu J, Yang Y, Zhu Y Transl Oncol. 2024; 47:101950.

PMID: 38964032 PMC: 11283126. DOI: 10.1016/j.tranon.2024.101950.


Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma.

Kim D, Orr M, Yu X, Munshi H, Wang A, Trudeau C ACS Med Chem Lett. 2024; 15(2):258-264.

PMID: 38352843 PMC: 10860193. DOI: 10.1021/acsmedchemlett.3c00505.


References
1.
Kuma A, Matsui M, Mizushima N . LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy. 2007; 3(4):323-8. DOI: 10.4161/auto.4012. View

2.
Yang S, Xiao X, Meng X, Leslie K . A mechanism for synergy with combined mTOR and PI3 kinase inhibitors. PLoS One. 2011; 6(10):e26343. PMC: 3198385. DOI: 10.1371/journal.pone.0026343. View

3.
Zhuang W, Li B, Long L, Chen L, Huang Q, Liang Z . Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer. 2011; 129(11):2720-31. DOI: 10.1002/ijc.25975. View

4.
Sunayama J, Matsuda K, Sato A, Tachibana K, Suzuki K, Narita Y . Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells. 2010; 28(11):1930-9. DOI: 10.1002/stem.521. View

5.
Chiarini F, Grimaldi C, Ricci F, Tazzari P, Evangelisti C, Ognibene A . Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia. Cancer Res. 2010; 70(20):8097-107. DOI: 10.1158/0008-5472.CAN-10-1814. View